Pomalid 1 mg Capsules

Pomalid 1 mg Capsules contain Pomalidomide 1 mg as the active pharmaceutical ingredient. Pomalidomide belongs to a class of medicines known as immunomodulatory agents and is used in specialist-supervised treatment regimens for certain blood cancers.

Pomalidomide is primarily associated with the treatment of multiple myeloma, a cancer involving plasma cells in the bone marrow. Its use depends on the patient's medical condition, previous treatments and the applicable approved prescribing information.

This page provides general product information about Pomalid 1 mg Capsules, including their composition, therapeutic indications, safety considerations and storage requirements.

Pomalid 1 mg Capsules – Product Details

Product Name: Pomalid 1 mg Capsules

Active Ingredient: Pomalidomide

Strength: 1 mg

Dosage Form: Capsules

Route of Administration: Oral

Therapeutic Category: Antineoplastic / Immunomodulatory Agent

Prescription Status: Prescription-only medicine

Product specifications and packaging should be verified against the approved product documentation.

Uses and Indications of Pomalidomide

Pomalidomide is used in combination with other medicines for treating selected patients with multiple myeloma. Multiple myeloma is a type of blood cancer that develops when abnormal plasma cells accumulate in the bone marrow.

Treatment eligibility depends on factors such as previous therapies, disease progression, the patient's general health and the applicable national treatment guidelines.

Pomalidomide should only be prescribed by an appropriately qualified healthcare professional. Its indications and approved treatment combinations may vary between countries.

Dosage and Administration

Pomalidomide dosage is determined by the treating specialist according to the approved treatment protocol and individual patient requirements.

Although Pomalid 1 mg Capsules represent a specific available strength, this does not mean that 1 mg is the standard starting or recommended treatment dose.

Patients should follow their prescribed treatment schedule and should not independently change, interrupt or restart medication. The capsules should be administered according to the applicable approved prescribing information.

Side Effects and Safety Precautions

Pomalidomide can cause adverse reactions, some of which may require medical attention. Reported side effects include:

Neutropenia and other reductions in blood cell counts

Anaemia and fatigue

Constipation, nausea and diarrhoea

Respiratory infections

Increased risk of blood clots

Important safety warnings:

Embryo-fetal toxicity: Pomalidomide can cause severe birth defects and is contraindicated during pregnancy.

Thromboembolism: Venous and arterial blood clots are serious potential complications.

Blood-related toxicity: Regular blood count monitoring is important.

Liver toxicity: Liver function should be monitored as directed by the treating specialist.

Severe skin reactions: Serious skin reactions and hypersensitivity require prompt medical assessment.

Appropriate pregnancy prevention measures and other risk-management requirements must be followed according to local prescribing regulations.

Storage and Handling

Store Pomalid 1 mg Capsules according to the manufacturer's approved storage instructions. Keep the medicine in its original packaging and out of reach of children. Follow product-specific handling and disposal precautions.

Frequently Asked Questions

1. What is Pomalid 1 mg Capsule?

It is an oral capsule containing 1 mg of pomalidomide, an immunomodulatory medicine used in certain oncology treatment regimens.

2. What is Pomalidomide used for?

Pomalidomide is used in specialist-supervised treatment combinations for selected patients with multiple myeloma.

3. Is Pomalid 1 mg a prescription medicine?

Yes. Pomalidomide is a prescription medicine requiring specialist supervision and appropriate monitoring.

4. What are the important safety precautions?

Important precautions include pregnancy prevention, monitoring for blood clots, regular blood tests and assessment of liver function.

Medical Disclaimer: This content is provided for general pharmaceutical product information and educational purposes. It is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare professional and refer to the applicable approved prescribing information before using this medicine.

Published by: Cordium Pharmaceuticals Pvt. Ltd.